# Shanghai CardiMED Medical Treatment Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-cardimed-medical-treatment-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.cardimed-asia.com
- Total disclosed funding: $79M
- Latest round: Series D (Feb 25, 2022)
- Investors on record: 11

## About

Based in Shanghai, China and established in 2015, Shanghai CardiMED Medical Treatment Technology Co., Ltd., is a medical technology company that provides medical instruments for cardiovascular disease. The company's head office is in Turkey, and some branch offices are in the Netherlands, Germany, USA, Poland and Switzerland, and has become a global purchasing organization for medical devices. The company has delivered medical devices in nearly 50 countries. 

The company provides artificial biological heart valves that have been implanted exceeded 10,000 and covered 250 hospitals since it has a surgical valve registration certificate. The company also provides left ear clamping systems, biopatches, valvuloplasty rings, intraoperative stent systems, and interventional valve products.

## Funding rounds

- Series D, Feb 25, 2022, $79M — Decheng Capital, Huagai Capital, Zhongjin Qiyu (Suzhou) Equity Investment Fund Management, Sinosafe General Insurance, Xinjin Investment, Beijing Daxing Investment Group, Prospect Bridge, Ningbo Port Area Deheyuan Investment Management
- Series C, Sep 14, 2020 — Decheng Capital, Taikang Life Insurance
- Series B, Apr 10, 2018 — Zhongjin Qiyu (Suzhou) Equity Investment Fund Management
- Series B, Oct 17, 2017 — Detong Capital, YiMei Capital
- Series A, Dec 11, 2015 — Decheng Capital

## Investors

- Decheng Capital (https://capitalatlas.ai/funds/decheng-capital) — Series A, Series C, Series D
- Detong Capital (https://capitalatlas.ai/funds/detong-capital) — Series B
- YiMei Capital (https://capitalatlas.ai/funds/yimei-capital) — Series B
- Zhongjin Qiyu (Suzhou) Equity Investment Fund Management (https://capitalatlas.ai/funds/zhongjin-qiyu-suzhou-equity-investment-fund-management) — Series B, Series D
- Taikang Life Insurance — Series C
- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series D
- Sinosafe General Insurance — Series D
- Xinjin Investment (https://capitalatlas.ai/funds/xinjin-investment) — Series D
- Beijing Daxing Investment Group — Series D
- Prospect Bridge — Series D
- Ningbo Port Area Deheyuan Investment Management — Series D